Waverley Pharma Provides Update on its PARP-1 Inhibitor Program

Stock Information for F3 Uranium Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About F3 Uranium Corp.

Waverley Pharma Announces Annual and Special Meeting Election Results
Waverley Pharma Business Update
Waverley Pharma Announces Changes to Board of Directors
Waverley Pharma Business Update
Waverley Pharma Provides Business Update
Waverley Pharma Announces $3,000,000 Credit Facility
Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS England
Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS Scotland

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.